Ovarian carcinoma is one of three gynecological neoplasms. It typically develops as an
insidious disease, with few warning signs or symptoms, because the ovary is situated at a …

Primary cytoreductive surgery followed by platinum-based chemotherapy represents the
standard treatment for patients with advanced ovarian cancer. But some patients with …

Background Epithelial ovarian cancer (EOC) is one of the leading causes of cancer-related
death in women. Approximately 70% of patients with EOC are diagnosed in advanced stage …

OBJECTIVE: Neoadjuvant chemotherapy has been proposed as an alternative approach to
conventional radical surgery with an aim to improve morbidity and survival. General …

Purpose (s) To evaluate results of neoadjuvant chemotherapy (NACT) following debulking
surgery in patients with extensive metastatic disease and/or poor medical performance …

Objectives: Although presumed to be an objective variable, the extent of cytoreduction (no
residual disease [NRD], optimal, suboptimal) is subject to the assessment and interpretation …

Objective The aim of this study was to investigate the clinical efficacy of neoadjuvant
chemotherapy (NACT) and the prognostic factors for advanced epithelial ovarian cancer …

Background The purpose of the current study is to analyze the existing data regarding
neoadjuvant chemotherapy (NAC) in advanced epithelial ovarian cancer (EOC) using a …

Background Patients with advanced ovarian cancer should be treated by radical debulking
surgery aiming at complete tumor resection. Unfortunately about 70% of the patients present …

목적: Primary debulking operation remains the standard of treatment for advanced ovarian
cancer. However, residual tumor is present in majority of patients, which limits survival. In an …